Wolf-Hirschhorn Syndrome with Hyperparathyroidism: A Case Report and a Narrative Review of the Literature

Abstract Wolf-Hirschhorn syndrome (WHS) is a contiguous gene deletion condition. The WHS core phenotype includes developmental delays, intellectual disabilities, seizures, and distinctive facial features. Various other comorbidities have also been reported, such as hearing loss, heart defects, as well as eye problems and kidney problems. In this report, we present a case of WHS accompanied by hyperparathyroidism and hypercalcemia, which has not been previously reported. A girl was born at 37 weeks of gestation by vaginal delivery. She was small for the gestational age (2,045 g) and admitted to neonatal intensive care unit. She had typical WHS facial features and was found to have bilateral small kidneys associated with transient metabolic acidosis and renal insufficiency. She had right-sided sensorineural hearing loss, a small atrial septal defect, and colpocephaly and hypoplasia of corpus callosum. She had a single seizure which was well controlled with an oral antiepileptic medication. Cytogenetic studies demonstrated a large terminal chromosome 4p deletion (21.4 Mb) and 4p duplication (2.1 Mb) adjacent to the deletion. A unique finding in this patient is her consistently elevated levels of parathyroid hormone and serum calcium, suggesting hyperparathyroidism. We present this rare case along with a review of the literature and hope to draw an attention to a potential relationship between WHS and hyperparathyroidism.

[1]  D. Carey,et al.  Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population , 2020, American journal of human genetics.

[2]  F. Hazan,et al.  Do microdeletions lead to immune deficiency? , 2020, Central-European journal of immunology.

[3]  S. Marx,et al.  Neonatal Severe Hyperparathyroidism: Novel Insights from Calcium, PTH, and the CASR Gene. , 2019, The Journal of clinical endocrinology and metabolism.

[4]  A. Battaglia,et al.  International meeting on Wolf‐Hirschhorn syndrome: Update on the nosology and new insights on the pathogenic mechanisms for seizures and growth delay , 2019, American journal of medical genetics. Part A.

[5]  S. Marx New Concepts About Familial Isolated Hyperparathyroidism. , 2019, The Journal of clinical endocrinology and metabolism.

[6]  A. Arnold,et al.  Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas , 2019, The Journal of clinical endocrinology and metabolism.

[7]  Falchetti Alberto,et al.  Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism. , 2018, Best practice & research. Clinical endocrinology & metabolism.

[8]  A. Battaglia,et al.  Risk of hepatic neoplasms in Wolf–Hirschhorn syndrome (4p‐): Four new cases and review of the literature , 2018, American journal of medical genetics. Part A.

[9]  Falchetti Alberto Genetics of parathyroids disorders: Overview. , 2018, Best practice & research. Clinical endocrinology & metabolism.

[10]  Dongzhi Li,et al.  Prenatal diagnosis of Wolf-Hirschhorn syndrome: Ultrasonography and molecular karyotyping results. , 2018, European journal of obstetrics, gynecology, and reproductive biology.

[11]  S. Cheung,et al.  Prenatal diagnosis of Wolf–Hirschhorn syndrome: from ultrasound findings, diagnostic technology to genetic counseling , 2018, Archives of Gynecology and Obstetrics.

[12]  C. Leoni,et al.  Oligonephronia and Wolf‐Hirschhorn syndrome: A further observation , 2018, American journal of medical genetics. Part A.

[13]  M. Pelizzo,et al.  Specifying the molecular pattern of sporadic parathyroid tumorigenesis-The Y282D variant of the GCM2 gene. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  Pedro P. Rocha,et al.  Wolf-Hirschhorn Syndrome Candidate 1 Is Necessary for Correct Hematopoietic and B Cell Development. , 2017, Cell reports.

[15]  P. Gallagher,et al.  Hepatic Malignancy in an Infant with Wolf–Hirschhorn Syndrome , 2017, Fetal and pediatric pathology.

[16]  Julie C. Sapp,et al.  GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism. , 2016, American journal of human genetics.

[17]  A. Breman,et al.  4p16.3 microdeletions and microduplications detected by chromosomal microarray analysis: New insights into mechanisms and critical regions , 2016, American journal of medical genetics. Part A.

[18]  Sarah T South,et al.  Wolf–Hirschhorn syndrome: A review and update , 2015, American journal of medical genetics. Part C, Seminars in medical genetics.

[19]  M. Nie,et al.  Familial isolated primary hyperparathyroidism/hyperparathyroidism‐jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese , 2014, Clinical endocrinology.

[20]  A James Barkovich,et al.  Clinical, genetic and imaging findings identify new causes for corpus callosum development syndromes. , 2014, Brain : a journal of neurology.

[21]  S. E.,et al.  Phenotypic Variations in Wolfhirschhorn Syndrome , 2014 .

[22]  A. Beaufrère,et al.  Prenatal ultrasound findings observed in the Wolf-Hirschhorn syndrome: data from the registry of congenital malformations in Auvergne. , 2013, Birth defects research. Part A, Clinical and molecular teratology.

[23]  C. Rusu,et al.  Inverted duplication deletion of 8P: characterization by standard cytogenetic and SNP array analyses. , 2013, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.

[24]  B. Stack,et al.  Characterization of hyperparathyroidism in youth and adolescents: a literature review. , 2013, International journal of pediatric otorhinolaryngology.

[25]  J. Clayton-Smith,et al.  Identification of genomic loci contributing to agenesis of the corpus callosum , 2010, American journal of medical genetics. Part A.

[26]  S. Yu,et al.  Telomere Capture as a Frequent Mechanism for Stabilization of the Terminal Chromosomal Deletion Associated with Inverted Duplication , 2010, Cytogenetic and Genome Research.

[27]  C. Leoni,et al.  Wolf–Hirschhorn syndrome with improvement of renal function , 2010, American journal of medical genetics. Part A.

[28]  M. Roselló,et al.  Submicroscopic Duplication of the Wolf-Hirschhorn Critical Region with a 4p Terminal Deletion , 2009, Cytogenetic and Genome Research.

[29]  S. Çetinkaya,et al.  Hyperparathyroidism secondary to maternal hypoparathyroidism and vitamin D deficiency: an uncommon cause of neonatal respiratory distress , 2009, Annals of tropical paediatrics.

[30]  S. South,et al.  U-type exchange is the most frequent mechanism for inverted duplication with terminal deletion rearrangements , 2009, Journal of Medical Genetics.

[31]  A. Battaglia,et al.  Wolf–Hirschhorn syndrome and the 4p‐related syndromes , 2008, American journal of medical genetics. Part C, Seminars in medical genetics.

[32]  A. Battaglia,et al.  Update on the clinical features and natural history of Wolf–Hirschhorn (4p‐) syndrome: Experience with 87 patients and recommendations for routine health supervision , 2008, American journal of medical genetics. Part C, Seminars in medical genetics.

[33]  G. Neri,et al.  On the nosology and pathogenesis of Wolf–Hirschhorn syndrome: Genotype–phenotype correlation analysis of 80 patients and literature review , 2008, American journal of medical genetics. Part C, Seminars in medical genetics.

[34]  Yun-Shien Lee,et al.  Microarray-based comparative genomic hybridization analysis of Wolf-Hirschhorn syndrome in a fetus with deletion of 4p15.3 to 4pter. , 2006, Birth defects research. Part A, Clinical and molecular teratology.

[35]  Z. Kavak,et al.  Prenatal diagnosis of Wolf-Hirschhorn syndrome (4p-) in association with congenital diaphragmatic hernia, cystic hygroma and IUGR. , 2006, Clinical and experimental obstetrics & gynecology.

[36]  Y. Soong,et al.  Prenatal diagnosis of monosomy 4p14→pter and trisomy 11q25→qter: clinical presentations and outcomes , 2005, Prenatal diagnosis.

[37]  D. Rodeberg,et al.  Primary Hyperparathyroidism in Pediatric Patients , 2005, Pediatrics.

[38]  K. Brøndum‐Nielsen,et al.  Brothers with Chudley–McCullough syndrome: Sensorineural deafness, agenesis of the corpus callosum, and other structural brain abnormalities , 2004, American journal of medical genetics. Part A.

[39]  F. Locatelli,et al.  Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[40]  A. Battaglia,et al.  Genotype-phenotype correlations and clinical diagnostic criteria in Wolf-Hirschhorn syndrome. , 2000, American journal of medical genetics.

[41]  A. Battaglia,et al.  Wolf-Hirschhorn syndrome (WHS): a history in pictures. , 2000, Clinical dysmorphology.

[42]  M. Altherr,et al.  "Tandem" duplication of 4p16.1p16.3 chromosome region associated with 4p16.3pter molecular deletion resulting in Wolf-Hirschhorn syndrome phenotype. , 1999, American journal of medical genetics.

[43]  E. Stiehm,et al.  Antibody deficiency in Wolf-Hirschhorn syndrome. , 1998, The Journal of pediatrics.

[44]  G. Hendy,et al.  Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene. , 1997, American journal of medical genetics.

[45]  J. Featherstone,et al.  Proton‐induced physicochemical calcium release from ceramic apatite disks , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[46]  A. Battaglia,et al.  Wolf-Hirschhorn Syndrome – ARCHIVED CHAPTER, FOR HISTORICAL REFERENCE ONLY , 1993 .

[47]  B. Piraino,et al.  Hypercalcemia in patients with advanced chronic renal failure not yet requiring dialysis. , 1989, American journal of nephrology.

[48]  M. Krause,et al.  Pathologic study of parathyroid glands in tertiary hyperparathyroidism. , 1985, Human pathology.

[49]  K. Hirschhorn,et al.  Chromosomal aberrations in human disease. A review of the status of cytogenetics in medicine. , 1961, The American journal of medicine.